(Adapted from an evidence-based guideline created using the National Prehospital Evidence-Based Guideline Model Process)
Aliases
None noted
Patient Care Goals
- Alleviate respiratory distress
- Promptly identify respiratory distress, respiratory failure, and respiratory arrest, and intervene for patients who require escalation of therapy
- Deliver appropriate therapy by differentiating other causes of pediatric respiratory distress
Patient Presentation
Inclusion Criteria
Suspected croup (history of stridor or history of barky cough)
Exclusion Criteria
- Presumed underlying cause that includes one of the following:
- Anaphylaxis
- Asthma
- Bronchiolitis (wheezing 2 yo)
- Foreign body aspiration
- Submersion/drowning
- Epiglottitis
Patient Management
Assessment
- History
- Onset of symptoms (history of choking)
- Concurrent symptoms (fever, cough, rhinorrhea, tongue/lip swelling, rash, labored breathing, foreign body aspiration)
- Sick contacts
- Treatments given
- Personal history of asthma, wheezing, or croup in past
- Exam
- Full set of vital signs (T, BP, RR, P, O2 sat)
- Presence of stridor at rest or when agitated
- Description of cough
- Other signs of distress (grunting, nasal flaring, retracting)
- Color (pallor, cyanosis, normal)
- Mental status (alert, tired, lethargic, unresponsive)
Treatment and Interventions
- Monitoring
- Pulse oximetry and end-tidal CO2(ETCO2) should be routinely used as an adjunct to other forms of respiratory monitoring
- Perform EKG only if there are no signs of clinical improvement after treating respiratory distress
- Airway
- Give supplemental oxygen. Escalate from a nasal cannula to a non-breather mask as needed, in order to maintain normal oxygenation
- Suction the nose and/or mouth (via bulb, Yankauer®, or suction catheter) if excessive secretions are present
- Inhaled Epinephrine should be administered to all children with croup in respiratory distress with signs of stridor at rest – this medication should be repeated at this dose with unlimited frequency for ongoing distress. Choose one of the following:
- Racemic Epinephrine: Nebulize 0.5 ml (11.25 mg) & 3 mL of Normal Saline together
- Cardiac Arrest Epinephrine: Nebulize 5 mL of 0.1 mg/mL (0.5 mg)
- Medications – dexamethasone 0.6 mg/kg oral, IV, or IM to maximum dose of 10 mg should be administered to patients with suspected croup
- Utility of IV placement and fluids – IVs should only be placed in children with respiratory distress for clinical concerns of dehydration, or when administering IV medications
- Improvement of oxygenation and/or respiratory distress with non-invasive airway adjuncts
- Bag-valve-mask ventilation should be utilized in children with respiratory failure
- Extraglottic devices and intubation – extraglottic devices and intubation should be utilized only if bag-valve-mask ventilation fails. The airway should be managed in the least invasive way possible